T 62

Drug Profile

T 62

Alternative Names: T-62

Latest Information Update: 10 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator King Pharmaceuticals
  • Class Analgesics
  • Mechanism of Action Adenosine A1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postherpetic neuralgia

Most Recent Events

  • 27 Dec 2008 Phase-II clinical trials in Postherpetic neuralgia in USA (PO)
  • 03 Aug 2007 Phase-II clinical trials in Postherpetic neuralgia in USA (PO)
  • 01 Jun 2004 A preclinical study has been added to the Pain pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top